Senior Vice President, Site Head
Since joining Vertex in 2002, Dr. Hadida has led the company’s chemistry team that is working in cystic fibrosis (CF) and pain. During that time, the team has discovered the now-approved medicines, KAL YD ECO, ORKAMBI, SYMDEKO and TRIKAFT A as well as multiple medicines in pre-clinical and clinical development. In June 2022, Dr. Hadida transitioned to lead the San Diego site.
Previously, Dr. Hadida held a research scientist position at Combichem, Inc. in San Diego, which later was bought by DuPont Pharmaceuticals, Bristol Myers-Squibb, and Deltagen Research Laboratories. Dr. Hadida received her Bachelor’s, Master’s and PhD in Pharmacy from the University of Barcelona, Spain. Additionally, she spent two years conducting postdoctoral research on fluorous chemistry at the University of Pittsburgh.